Muller WJ - Search Results

1

Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth.

Andrechek ER, White D, Muller WJ. Andrechek ER, et al. Among authors: muller wj. Oncogene. 2005 Jan 27;24(5):932-7. doi: 10.1038/sj.onc.1208230. Oncogene. 2005. PMID: 15580295

2

ErbB2 is required for muscle spindle and myoblast cell survival.

Andrechek ER, Hardy WR, Girgis-Gabardo AA, Perry RL, Butler R, Graham FL, Kahn RC, Rudnicki MA, Muller WJ. Andrechek ER, et al. Among authors: muller wj. Mol Cell Biol. 2002 Jul;22(13):4714-22. doi: 10.1128/MCB.22.13.4714-4722.2002. Mol Cell Biol. 2002. PMID: 12052879 Free PMC article.

3

Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers.

Andrechek ER, Laing MA, Girgis-Gabardo AA, Siegel PM, Cardiff RD, Muller WJ. Andrechek ER, et al. Among authors: muller wj. Cancer Res. 2003 Aug 15;63(16):4920-6. Cancer Res. 2003. PMID: 12941816

4

Germ-line expression of an oncogenic erbB2 allele confers resistance to erbB2-induced mammary tumorigenesis.

Andrechek ER, Hardy WR, Laing MA, Muller WJ. Andrechek ER, et al. Among authors: muller wj. Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4984-9. doi: 10.1073/pnas.0306802101. Epub 2004 Mar 29. Proc Natl Acad Sci U S A. 2004. PMID: 15051890 Free PMC article.

5

Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction.

White DE, Kurpios NA, Zuo D, Hassell JA, Blaess S, Mueller U, Muller WJ. White DE, et al. Among authors: muller wj. Cancer Cell. 2004 Aug;6(2):159-70. doi: 10.1016/j.ccr.2004.06.025. Cancer Cell. 2004. PMID: 15324699 Free article.

6

Developmental timing of activated erbB2 expression plays a critical role in the induction of mammary tumors.

Andrechek ER, Muller WJ. Andrechek ER, et al. Among authors: muller wj. Cell Cycle. 2004 Sep;3(9):1111-3. Epub 2004 Sep 1. Cell Cycle. 2004. PMID: 15326381 Review.

7

Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu.

Montagna C, Andrechek ER, Padilla-Nash H, Muller WJ, Ried T. Montagna C, et al. Among authors: muller wj. Oncogene. 2002 Jan 31;21(6):890-8. doi: 10.1038/sj.onc.1205146. Oncogene. 2002. PMID: 11840334

8

Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.

Andrechek ER, Hardy WR, Siegel PM, Rudnicki MA, Cardiff RD, Muller WJ. Andrechek ER, et al. Among authors: muller wj. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3444-9. doi: 10.1073/pnas.97.7.3444. Proc Natl Acad Sci U S A. 2000. PMID: 10716706 Free PMC article.

9

Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer.

Andrechek ER, Muller WJ. Andrechek ER, et al. Among authors: muller wj. Breast Cancer Res. 2000;2(3):211-6. doi: 10.1186/bcr56. Epub 2000 Apr 12. Breast Cancer Res. 2000. PMID: 11250712 Free PMC article. Review.

10

Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.

White DE, Cardiff RD, Dedhar S, Muller WJ. White DE, et al. Among authors: muller wj. Oncogene. 2001 Oct 25;20(48):7064-72. doi: 10.1038/sj.onc.1204910. Oncogene. 2001. PMID: 11704830

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

376 results

Search Page